Verheijen R, de Jong B A, van Venrooij W J
Department of Biochemistry, University of Nijmegen, The Netherlands.
Clin Exp Immunol. 1992 Sep;89(3):456-60. doi: 10.1111/j.1365-2249.1992.tb06980.x.
An ELISA for the detection of anti-topoisomerase I autoantibodies in sera from patients with suspected or manifest rheumatic diseases is described. The antigen source used in this assay consists of a recombinant protein containing the last 695 C-terminal amino acid residues of human topoisomerase I (topo I). The sensitivity of the assay was 61%, while the specificity was more than 98%. Using this ELISA, 47 sera from scleroderma patients and immunopositive for anti-topo I antibodies, were screened for the presence of the isotypes IgG, IgA and IgM to topo I. Our finding that relatively high levels of IgA antibodies to topo I are present in most of the sera tested is consistent with the results of Hildebrandt et al. [1]. In addition, it is demonstrated that the IgG and IgA antibodies in a serum may recognize different epitope regions on the topo I polypeptide.
本文描述了一种用于检测疑似或确诊风湿性疾病患者血清中抗拓扑异构酶I自身抗体的酶联免疫吸附测定(ELISA)。该检测中使用的抗原来源是一种重组蛋白,其包含人拓扑异构酶I(topo I)的最后695个C末端氨基酸残基。该检测的灵敏度为61%,而特异性超过98%。使用此ELISA,对47份来自硬皮病患者且抗topo I抗体免疫阳性的血清进行检测,以筛查针对topo I的IgG、IgA和IgM同种型的存在情况。我们的研究发现,在大多数检测血清中存在相对高水平的针对topo I的IgA抗体,这与希尔德布兰特等人[1]的结果一致。此外,研究表明血清中的IgG和IgA抗体可能识别topo I多肽上不同的表位区域。